97 related articles for article (PubMed ID: 29532864)
1. Long non-coding RNA KCNQ1OT1 mediates the growth of hepatocellular carcinoma by functioning as a competing endogenous RNA of miR-504.
Li C; Miao R; Zhang J; Qu K; Liu C
Int J Oncol; 2018 May; 52(5):1603-1612. PubMed ID: 29532864
[TBL] [Abstract][Full Text] [Related]
2. Downregulation of Long Non-Coding RNA Kcnq1ot1: An Important Mechanism of Arsenic Trioxide-Induced Long QT Syndrome.
Jiang Y; Du W; Chu Q; Qin Y; Tuguzbaeva G; Wang H; Li A; Li G; Li Y; Chai L; Yue E; Sun X; Wang Z; Pavlov V; Yang B; Bai Y
Cell Physiol Biochem; 2018; 45(1):192-202. PubMed ID: 29339628
[TBL] [Abstract][Full Text] [Related]
3. A novel lncRNA MCM3AP-AS1 promotes the growth of hepatocellular carcinoma by targeting miR-194-5p/FOXA1 axis.
Wang Y; Yang L; Chen T; Liu X; Guo Y; Zhu Q; Tong X; Yang W; Xu Q; Huang D; Tu K
Mol Cancer; 2019 Feb; 18(1):28. PubMed ID: 30782188
[TBL] [Abstract][Full Text] [Related]
4. LncRNA KTN1-AS1 promotes tumor growth of hepatocellular carcinoma by targeting miR-23c/ERBB2IP axis.
Zhang L; Wang L; Wang Y; Chen T; Liu R; Yang W; Liu Q; Tu K
Biomed Pharmacother; 2019 Jan; 109():1140-1147. PubMed ID: 30551364
[TBL] [Abstract][Full Text] [Related]
5. KCNQ1OT1: An Oncogenic Long Noncoding RNA.
Cagle P; Qi Q; Niture S; Kumar D
Biomolecules; 2021 Oct; 11(11):. PubMed ID: 34827600
[TBL] [Abstract][Full Text] [Related]
6. Long noncoding RNA KCNQ1OT1 is correlated with human breast cancer cell development through inverse regulation of hsa-miR-107.
Wu Y; Bi QJ; Han R; Zhang Y
Biochem Cell Biol; 2020 Jun; 98(3):338-344. PubMed ID: 32379482
[TBL] [Abstract][Full Text] [Related]
7. Knockdown of Long Non-Coding RNA KCNQ1OT1 Restrained Glioma Cells' Malignancy by Activating miR-370/CCNE2 Axis.
Gong W; Zheng J; Liu X; Liu Y; Guo J; Gao Y; Tao W; Chen J; Li Z; Ma J; Xue Y
Front Cell Neurosci; 2017; 11():84. PubMed ID: 28381990
[TBL] [Abstract][Full Text] [Related]
8. Knockdown of KCNQ1OT1 Suppresses Cell Invasion and Sensitizes Osteosarcoma Cells to CDDP by Upregulating DNMT1-Mediated Kcnq1 Expression.
Qi X; Yu XJ; Wang XM; Song TN; Zhang J; Guo XZ; Li GJ; Shao M
Mol Ther Nucleic Acids; 2019 Sep; 17():804-818. PubMed ID: 31454677
[TBL] [Abstract][Full Text] [Related]
9. Long non-coding RNA KCNQ1OT1 modulates oxaliplatin resistance in hepatocellular carcinoma through miR-7-5p/ ABCC1 axis.
Hu H; Yang L; Li L; Zeng C
Biochem Biophys Res Commun; 2018 Sep; 503(4):2400-2406. PubMed ID: 29966655
[TBL] [Abstract][Full Text] [Related]
10. Long non-coding RNA PTTG3P functions as an oncogene by sponging miR-383 and up-regulating CCND1 and PARP2 in hepatocellular carcinoma.
Zhou Q; Zhang W; Wang Z; Liu S
BMC Cancer; 2019 Jul; 19(1):731. PubMed ID: 31340767
[TBL] [Abstract][Full Text] [Related]
11. LncRNA DCST1-AS1 functions as a competing endogenous RNA to regulate FAIM2 expression by sponging miR-1254 in hepatocellular carcinoma.
Chen J; Wu D; Zhang Y; Yang Y; Duan Y; An Y
Clin Sci (Lond); 2019 Jan; 133(2):367-379. PubMed ID: 30617187
[TBL] [Abstract][Full Text] [Related]
12. KCNQ1OT1 lncRNA affects the proliferation, apoptosis, and chemoresistance of small cell lung cancer cells via the JAK2/STAT3 axis.
Zhu Y; Shen Y; Chen R; Li H; Wu Y; Zhang F; Huang W; Guo L; Chen Q; Liu H
Ann Transl Med; 2021 May; 9(10):891. PubMed ID: 34164525
[TBL] [Abstract][Full Text] [Related]
13. LncRNA KCNQ1OT1: Molecular mechanisms and pathogenic roles in human diseases.
Xia F; Wang Y; Xue M; Zhu L; Jia D; Shi Y; Gao Y; Li L; Li Y; Chen S; Xu G; Yuan D; Yuan C
Genes Dis; 2022 Nov; 9(6):1556-1565. PubMed ID: 36157505
[TBL] [Abstract][Full Text] [Related]
14. HOXA-AS2 Promotes Proliferation and Induces Epithelial-Mesenchymal Transition via the miR-520c-3p/GPC3 Axis in Hepatocellular Carcinoma.
Zhang Y; Xu J; Zhang S; An J; Zhang J; Huang J; Jin Y
Cell Physiol Biochem; 2018; 50(6):2124-2138. PubMed ID: 30415263
[TBL] [Abstract][Full Text] [Related]
15. Long noncoding RNAs: Novel insights into hepatocelluar carcinoma.
He Y; Meng XM; Huang C; Wu BM; Zhang L; Lv XW; Li J
Cancer Lett; 2014 Mar; 344(1):20-27. PubMed ID: 24183851
[TBL] [Abstract][Full Text] [Related]
16. LncRNA DBH-AS1 facilitates the tumorigenesis of hepatocellular carcinoma by targeting miR-138 via FAK/Src/ERK pathway.
Bao J; Chen X; Hou Y; Kang G; Li Q; Xu Y
Biomed Pharmacother; 2018 Nov; 107():824-833. PubMed ID: 30142544
[TBL] [Abstract][Full Text] [Related]
17. LncRNA KCNQ1OT1 acting as a ceRNA for miR-4458 enhances osteosarcoma progression by regulating CCND2 expression.
Wang M; Wang Z; Zhu X; Guan S; Liu Z
In Vitro Cell Dev Biol Anim; 2019 Oct; 55(9):694-702. PubMed ID: 31392505
[TBL] [Abstract][Full Text] [Related]
18. Long non-coding RNA SBF2-AS1 promotes hepatocellular carcinoma progression through regulation of miR-140-5p-TGFBR1 pathway.
Li Y; Liu G; Li X; Dong H; Xiao W; Lu S
Biochem Biophys Res Commun; 2018 Sep; 503(4):2826-2832. PubMed ID: 30115383
[TBL] [Abstract][Full Text] [Related]
19. Ftx non coding RNA-derived miR-545 promotes cell proliferation by targeting RIG-I in hepatocellular carcinoma.
Liu Z; Dou C; Yao B; Xu M; Ding L; Wang Y; Jia Y; Li Q; Zhang H; Tu K; Song T; Liu Q
Oncotarget; 2016 May; 7(18):25350-65. PubMed ID: 26992218
[TBL] [Abstract][Full Text] [Related]
20. Long non-coding RNA HOTTIP is frequently up-regulated in hepatocellular carcinoma and is targeted by tumour suppressive miR-125b.
Tsang FH; Au SL; Wei L; Fan DN; Lee JM; Wong CC; Ng IO; Wong CM
Liver Int; 2015 May; 35(5):1597-606. PubMed ID: 25424744
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
